The Scottish Medicines Consortium (SMC) has approved the use of Alcon's Nevanac in patients suffering from diabetes to minimize the possibility of postoperative macular oedema (MO) coupled with cataract surgery. The approval allows the ...
Tags: The Scottish Medicines Consortium, diabetic cataract patients, Medicine